Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCEL
3701
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $46.5K | ﹤0.01% |
47,487
| – | – |
|
3702
Willdan Group
WLDN
$1.04B
| $46.5K | ﹤0.01% |
2,427
-3,491
| -59% | -$58.7K |
|
3703
Organogenesis Holdings
ORGO
$305M
| $46.5K | ﹤0.01% |
13,992
-88,836
| -86% | -$263K |
|
3704
Full House Resorts
FLL
$80.1M
| $46.4K | ﹤0.01% |
6,920
-9,738
| -58% | -$67K |
|
3705
Vertical Aerospace
EVTL
$158M
| $46.3K | ﹤0.01% |
+2,351
| New | +$44.4K |
|
|
ADAP
3706
DELISTED
Adaptimmune Therapeutics
ADAP
| $46.3K | ﹤0.01% |
+50,061
| New | +$59.7K |
|
|
SI
3707
DELISTED
Silvergate Capital Corporation
SI
| $46.3K | ﹤0.01% |
66,102
-558,787
| -89% | -$789K |
|
|
FITE
3708
State Street SPDR S&P Kensho Future Security ETF
FITE
$143M
| $46.2K | ﹤0.01% |
946
| – | – |
|
3709
P3 Health Partners
PIII
$32.7M
| $46.1K | ﹤0.01% |
309
+69
| +29% | +$9.54K |
|
3710
USA Compression Partners
USAC
$3.79B
| $46.1K | ﹤0.01% |
2,336
-551
| -19% | -$11.1K |
|
3711
CPI Card Group
PMTS
$242M
| $46K | ﹤0.01% |
1,977
-5,514
| -74% | -$177K |
|
|
PBPB
3712
DELISTED
Potbelly
PBPB
| $45.9K | ﹤0.01% |
5,229
-5,253
| -50% | -$46.1K |
|
3713
Culp Inc
CULP
$44.1M
| $45.9K | ﹤0.01% |
9,228
| – | – |
|
3714
Red Violet
RDVT
$979M
| $45.8K | ﹤0.01% |
2,227
-2,711
| -55% | -$50.6K |
|
|
BHIL
3715
DELISTED
Benson Hill, Inc.
BHIL
| $45.6K | ﹤0.01% |
1,003
-1,478
| -60% | -$63.3K |
|
3716
Immersion
IMMR
$251M
| $45.1K | ﹤0.01% |
6,367
-27,864
| -81% | -$206K |
|
|
NOTE
3717
DELISTED
FiscalNote
NOTE
| $45K | ﹤0.01% |
1,030
-2,763
| -73% | -$77.6K |
|
|
AFMD
3718
DELISTED
Affimed
AFMD
| $45K | ﹤0.01% |
7,517
-8,304
| -52% | -$66.6K |
|
3719
SEALSQ Corp
LAES
$526M
| $44.9K | ﹤0.01% |
+1,105
| New | +$15.5K |
|
3720
Global X Autonomous & Electric Vehicles ETF
DRIV
$377M
| $44.9K | ﹤0.01% |
1,725
-103
| -6% | -$2.44K |
|
3721
374Water
SCWO
$38.1M
| $44.8K | ﹤0.01% |
+1,874
| New | +$59.8K |
|
3722
Arhaus
ARHS
$1.05B
| $44.7K | ﹤0.01% |
4,289
+4,288
| +428,800% | +$35K |
|
3723
Nathan's Famous
NATH
$402M
| $44.5K | ﹤0.01% |
566
-655
| -54% | -$48.9K |
|
3724
Oculis Holding
OCS
$683M
| $44.4K | ﹤0.01% |
+3,602
| New | +$40.2K |
|
|
THRN
3725
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $44.2K | ﹤0.01% |
9,396
-4,365
| -32% | -$20.1K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.